Frontlight ResearchEarly access
Trial site
Digestive Healthcare of Georgia
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Primary biliary cholangitis4 trials
- Crohn's disease3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Gilead Sciences2 trials
- COUR Pharmaceutical Development Company, Inc.1 trial
- Hoffmann-La Roche1 trial
- Inventiva Pharma1 trial
- and 4 more
Running trials
Recruiting
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Primary biliary cholangitis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026